NCT03332719View on ClinicalTrials.gov

Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

September 30, 2017

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Etanercept

DRUG

Methotrexate

Trial Locations (1)

Unknown

Instituto Medico CER, Bs As

Sponsors

Lead Sponsor

Gema Biotech S.A.
All Listed Sponsors
collaborator

QUID Quality in Drugs and Devices Latin American Consulting SRL

OTHER

lead

Gema Biotech S.A.

INDUSTRY